20250177376. Alpha (University of Virginia Patent Foundation): Difference between revisions
Wikipatents (talk | contribs) Automated patent report |
Wikipatents (talk | contribs) Automated patent report |
||
| Line 19: | Line 19: | ||
<!-- JSON-LD markup for search engines: | <!-- JSON-LD markup for search engines: | ||
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250177376. Alpha (University of Virginia Patent Foundation)","name":"20250177376. Alpha (University of Virginia Patent Foundation)","description":"Patent application abstract and classification for 20250177376 - Alpha","datePublished":"2025-06- | {"@context":"https://schema.org","@type":"TechArticle","headline":"20250177376. Alpha (University of Virginia Patent Foundation)","name":"20250177376. Alpha (University of Virginia Patent Foundation)","description":"Patent application abstract and classification for 20250177376 - Alpha","datePublished":"2025-06-10","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250177376","name":"Alpha","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"University of Virginia Patent Foundation"}]}} | ||
--> | --> | ||
Revision as of 17:57, 10 June 2025
ALPHA 2 ADRENERGIC RECEPTOR BLOCKADE FOR THE TREATMENT OF C. DIFFICILE COLITIS
Abstract: provided are methods and compositions for treating and/or preventing infections, particularly recurring infections. the compositions for use in treating and/or preventing infections include in some embodiments at least one agent that inhibits an alpha 2 adrenergic receptor, and the presently disclosed methods include administering at least one such composition to a subject in need thereof, optionally in combination with other therapeutically active agents including but not limited to an enhancer of an il-13 biological activity, optionally an il-13 peptide or a fragment or homolog thereof; an interleukin-13 receptor subunit alpha-2 (il-13ra2) inhibitor; an enhancer of an interleukin-33 (il-33) biological activity, optionally an il-33 polypeptide or a biologically active fragment or homolog thereof; or any combination thereof.
Inventor(s): William A. Petri, Jr., David Tyus
CPC Classification: A61K31/4745 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250177376